Who Just Raised

BioLineRx Ltd.

Modi'In, Israel ยท Biotechnology

BioLineRx Ltd. is a biotechnology company based in Modi'In, Israel. In a Form D filed with the SEC on September 9, 2026, it reported raising $3,750,000 from 1 investor as part of an offering of up to $3,750,000. The first sale in the offering took place on August 27, 2026.

100% of the $3.8M offering sold so far

BioLineRx is building a best-in-class pipeline designed to deliver meaningful therapeutic benefit to patients with certain cancers and rare diseases.

Website
biolinerx.com
Amount raised
$3,750,000
Offering size
$3,750,000
Investors so far
1
First sale
August 27, 2026
Securities offered
Options or warrants, Securities issuable on exercise or conversion
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Modi'In, Israel
Incorporated
Israel
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $3,750,000 $3,750,000 1 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises

Company Location Sector Raised Target Filed
Curadel Surgical Innovations, Inc. Bonita Springs, FL Health Care $49.8M $57.5M
Axelyf, Inc. Chestnut Hill, MA Health Care $2.6M $2.7M
iPill Inc. Rowland Heights, CA Health Care $1.3M $1.5M
Dvant Pharma, Inc. Superior Township, MI Health Care $1.2M $3.1M
FibroBiologics, Inc. Houston, TX Health Care $1.2M $1.2M
Vimy Pharmaceuticals Inc. Toronto, Ontario, Canada Health Care $1M $1M